SOYACAL 10% Drug Patent Profile
When do Soyacal 10% patents expire, and when can generic versions of Soyacal 10% launch?
Soyacal 10% is a drug marketed by Alpha Thera and is included in one NDA.
The generic ingredient in SOYACAL 10% is soybean oil. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SOYACAL 10%?
- What are the global sales for SOYACAL 10%?
- What is Average Wholesale Price for SOYACAL 10%?
Summary for SOYACAL 10%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | SOYACAL 10% at DailyMed |
US Patents and Regulatory Information for SOYACAL 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Thera | SOYACAL 10% | soybean oil | INJECTABLE;INJECTION | 018465-001 | Jun 29, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
